Bharat Immunologicals & Biologicals shareholders and shareholding pattern
BSE: 524663Pharmaceuticals & BiotechnologySmall Cap
Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994
Last close ₹8.95up ₹0.07 (0.79%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹8.88.
29 Oct: open ₹9.10, high ₹9.10, low ₹8.70
52-week range of traded prices to 29 Oct 2026
₹7.11Low, 6 Oct 2026₹22.61High, 23 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 28 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,103rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 16,670
Bharat Immunologicals & Biologicals' shareholding pattern for Mar 2024, filed on 21 Apr 2024, with every filing from Jun 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Bharat Immunologicals & Biologicals, filing by filing
Per cent of the company's shares.
31 Mar 2024 filing
- Promoters59.25%
- Individuals and others40.75%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Individuals and others
| Per cent | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Dec 2023 | Mar 202431 Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | |
| Indian promoters | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% | 40.75% |
| Shares in issue | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 | 4,31,80,000 |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Bharat Immunologicals & Biologicals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing of 31 Mar 2024; the largest is PRESIDENT OF INDIA, 59.25%.
| Holder | |||
|---|---|---|---|
| PRESIDENT OF INDIACentral and state governments | 59.25% | 2,55,85,993 | 2,55,85,993 |
| DR RAJESH S GOKHALE, SECRETARY DBTIndividuals and Hindu undivided familiesHindu undivided family. A family the tax law treats as one holder: property held in the family's name, shared by its members and managed by one of them. Hindu undivided family in the glossary | 0.00% | 1 | 0 |
| DR NITIN K JAIN, SCIENTIST G, DBTIndividuals and Hindu undivided families | 0.00% | 1 | 0 |
| DR DHANANJAY TIWARY, SCIENTIST G, DBTIndividuals and Hindu undivided families | 0.00% | 1 | 0 |
| DR ALKA SHARMA, SCIENTIST H, DBTIndividuals and Hindu undivided families | 0.00% | 1 | 0 |
| SH PANKAJ UPADHYAY, DS, DBTIndividuals and Hindu undivided families | 0.00% | 1 | 0 |
| SH VISHWAJIT SAHAY AS&FA, DBTIndividuals and Hindu undivided families | 0.00% | 1 | 0 |
| DR SANJAY MISHRA, SCIENTIST H, DBTIndividuals and Hindu undivided families | 0.00% | 1 | 0 |
No promoter shares are reported as pledged. In demat is the part of the holding kept electronically; the rest is paper certificates.
Largest public holders of Bharat Immunologicals & Biologicals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Dec 2023 | Mar 202431 Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TRUSTSOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00% | – | – | – | – |
| TOPGAIN FINANCE PRIVATE LIMITEDNon-bank lenders registered with RBI | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | – | – | – | – | – | – | – | – |
| INDIVUDUAL SHAREHOLDERSResident individuals, up to ₹2 lakh at face value | – | – | 21.26% | 21.44% | 21.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| JAINAM SHARE CONSULTANTS PVT LTDOther non-institutions | – | 1.09% | – | 1.07% | 1.10% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| 72 NUMBER OF SHAREHOLDERSResident individuals, over ₹2 lakh at face value | 10.77% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.